FollowMyHealth Patient Portal

John T. Lind, MD, MS

Associate Professor, Ophthalmology and Visual Sciences

Specialty Areas

Ophthalmology
Glaucoma

Board Certifications

Ophthalmology

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Complications of glaucoma surgery, medical, laser and surgical treatment of glaucoma, resident and medical student education

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Eye Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 12
Office Phone: 314-362-EYES
Fax: 314-362-3725

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Office Phone: 314-996-3300
Fax: 314-996-3490

Education

Education

Fellowship: Glaucoma, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida 2009
Medical Degree: Indiana University School of Medicine, Indianapolis, Indiana 2004
B.S.: Indiana University, Indianapolis, Indiana 1999
Residency: Ophthalmology, Saint Louis University Eye Institute, St. Louis, Missouri 2008
Master of Science: Biology, Purdue University, Indianapolis, Indiana 2000

Publication & Research

Publication & Research

Patch graft materials for glaucoma tube implants.
Lind JT, Shute TS, Sheybani A
Curr Opin Ophthalmol. 2017 Mar; 28(2)194-198. doi: 10.1097/ICU.0000000000000347.

PMID:
    27828897
    [PubMed - indexed for MEDLINE]
Related citations


Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL, NORDIC Idiopathic Intracranial Hypertension Study Group.
Invest Ophthalmol Vis Sci. 2016 Mar; 57(3)805-12. doi: 10.1167/iovs.15-18626.

PMID:
    26934136
    [PubMed - indexed for MEDLINE]
Related citations


Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.
Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group.
Neurology. 2015 Sep 1; 85(9)799-805. doi: 10.1212/WNL.0000000000001896.

PMID:
    26245929
    [PubMed - indexed for MEDLINE]
Related citations


Assessment of risk factors for oxacillin-resistant ocular flora in eyes having cataract surgery.
Hsu HY, Lind JT, Miller D, Tseng L
J Cataract Refract Surg. 2015 Feb; 41(2)387-92. doi: 10.1016/j.jcrs.2014.05.050.

PMID:
    25661133
    [PubMed - indexed for MEDLINE]
Related citations


Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group., Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS
Invest Ophthalmol Vis Sci. 2014 Nov 4; 55(12)8173-9. doi: 10.1167/iovs.14-14961.

PMID:
    25370513
    [PubMed - indexed for MEDLINE]
Related citations


Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group., Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS
Invest Ophthalmol Vis Sci. 2014 Nov 4; 55(12)8180-8. doi: 10.1167/iovs.14-14960.

PMID:
    25370510
    [PubMed - indexed for MEDLINE]
Related citations


Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee., Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ
JAMA. 2014 Apr 23-30; 311(16)1641-51. doi: 10.1001/jama.2014.3312.

PMID:
    24756514
    [PubMed - indexed for MEDLINE]
Related citations


The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group.
JAMA Neurol. 2014 Jun; 71(6)693-701. doi: 10.1001/jamaneurol.2014.133.

PMID:
    24756302
    [PubMed - indexed for MEDLINE]
Related citations


Surgical management of non-traumatic pediatric ectopia lentis: A case series and review of the literature.
Hsu HY, Edelstein SL, Lind JT
Saudi J Ophthalmol. 2012 Jul; 26(3)315-21. doi: 10.1016/j.sjopt.2012.05.001.

PMID:
    23961012
    [PubMed]
Related citations


Reply: To PMID 22995030.
Hsu HY, Lind JT
Am J Ophthalmol. 2013 Sep; 156(3)624. doi: 10.1016/j.ajo.2013.04.024.

PMID:
    23953156
    [PubMed - indexed for MEDLINE]
Related citations


Ocular flora and their antibiotic resistance patterns in the midwest: a prospective study of patients undergoing cataract surgery.
Hsu HY, Lind JT, Tseng L, Miller D
Am J Ophthalmol. 2013 Jan; 155(1)36-44.e2. doi: 10.1016/j.ajo.2012.06.024.

PMID:
    22995030
    [PubMed - indexed for MEDLINE]
Related citations


Nondisplacement of descemet stripping automated endothelial keratoplasty lenticule after traumatic rupture of the globe.
Hsu HY, Lind JT
Cornea. 2010 Feb; 29(2)217-9. doi: 10.1097/ICO.0b013e3181a16352.

PMID:
    20023591
    [PubMed - indexed for MEDLINE]
Related citations


Clinical experience with the Baerveldt 250-mm2 Glaucoma Implant.
WuDunn D, Phan AD, Cantor LB, Lind JT, Cortes A, Wu B
Ophthalmology. 2006 May; 113(5)766-72.

PMID:
    16650671
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2016.

Company Name: Allergan

Royalties:

Equity: No

Consulting/Advisory Board: $10,001 - $25,000

Speaker Fees:

Reporting Date: May 01, 2017